Evidence map›Paper›PMID 25646306›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

Macrophage mitochondrial and stress response to ingestion of Cryptococcus neoformans.

Carolina Coelho, Ana Camila Oliveira Souza, Lorena da Silveira Derengowski, Carlos de Leon-Rodriguez, Bo Wang, Rosiris Leon-Rivera, Anamelia Lorenzetti Bocca, Teresa Gonçalves, Arturo Casadevall

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Macrophage variants in laboratory research: most are well done, but some are RAW.Frontiers in cellular and infection microbiology · 2024
    Review
  9. Article
  10. Review
  11. Calcimycin InhibitsACS infectious diseases · 2022
    Article
  12. Journal of fungi (Basel, Switzerland) · 2022
    Review
  13. microLife · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. CoremBio · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 5 countries.

Carolina CoelhoDepartment of Microbiology and Immunology, Albert Einstein College of Medicine of Yeshiva University, Bronx, NY 10461; Centre for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal; Faculty of Medicine, University of Coimbra, 3004-504 Coimbra, Portugal;ORCID http://orcid.org/0000-0002-7523-3031
Ana Camila Oliveira SouzaCell Biology Department, Biology Science Institute, University of Brasilia, Brasilia CEP 70910-900, Brazil;
Lorena da Silveira DerengowskiCell Biology Department, Biology Science Institute, University of Brasilia, Brasilia CEP 70910-900, Brazil;
Carlos de Leon-RodriguezDepartment of Microbiology and Immunology, Albert Einstein College of Medicine of Yeshiva University, Bronx, NY 10461;
Bo WangDepartment of Microbiology and Immunology, Albert Einstein College of Medicine of Yeshiva University, Bronx, NY 10461; MD Program, Albert Einstein College of Medicine of Yeshiva University, Bronx, NY 10461;
Rosiris Leon-RiveraDepartment of Biology, University of Puerto Rico, Río Piedras Campus, San Juan, Puerto Rico 00931; and Undergraduate Research Program, Albert Einstein College of Medicine of Yeshiva University, Bronx, NY 10461.
Anamelia Lorenzetti BoccaCell Biology Department, Biology Science Institute, University of Brasilia, Brasilia CEP 70910-900, Brazil;
Teresa GonçalvesCentre for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal; Faculty of Medicine, University of Coimbra, 3004-504 Coimbra, Portugal;
Arturo CasadevallDepartment of Microbiology and Immunology, Albert Einstein College of Medicine of Yeshiva University, Bronx, NY 10461; arturo.casadevall@einstein.yu.edu.
Albert Einstein College of Medicine · USUniversidade de Brasília · BRUniversity of Coimbra · PT

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
WORD PROCESSORP30CA013330 · NCI · YESHIVA UNIVERSITY · PI THOMAS E ROHAN · 1985 to 2026
$111.2M
Washington University Institute of Clinical and Translational Sciences (UL1)UL1RR024992 · NCRR · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2007 to 2011
$45.4M
RIO PIEDRAS MARC U*STAR DEVELOPMENT PROGRAMT34GM007821 · NIGMS · UNIVERSITY OF PUERTO RICO RIO PIEDRAS · PI CARBALLEIRA, NESTOR MANUEL · 1985 to 2020
$20.3M
Synergy of Host Defense Mechanisms in the LungR01HL059842 · NHLBI · YESHIVA UNIVERSITY · PI CASADEVALL, ARTURO · 1997 to 2023
$7.4M
Biology of Fungal MelaninR01AI052733 · NIAID · YESHIVA UNIVERSITY · PI CASADEVALL, ARTURO · 2003 to 2019
$6.6M
PROTECTIVE ANTIBODIES FOR CRYPTOCOCCAL INFECTIONSR01AI033774 · NIAID · YESHIVA UNIVERSITY · PI CASADEVALL, ARTURO · 1994 to 2014
$5.6M
Molecular Characterization of C. neoformans AntibodiesR37AI033142 · NIAID · JOHNS HOPKINS UNIVERSITY · PI CASADEVALL, ARTURO · 2007 to 2016
$3.9M
MOLECULAR CHARACTERIZATION OF C NEOFORMANS ANTIBODIESR01AI033142 · NIAID · YESHIVA UNIVERSITY · PI CASADEVALL, ARTURO · 1994 to 2006
$1.7M
NCI NIH HHS P30 CA013330NCI NIH HHS P30CA013330NCI NIH HHS P30 CA091842NCI NIH HHS P30 CA91842NCRR NIH HHS UL1 RR024992NCRR NIH HHS UL1RR024992NHLBI NIH HHS 5R01HL059842NHLBI NIH HHS R01 HL059842NIAID NIH HHS 5R01AI033774NIAID NIH HHS 5R01AI052733NIAID NIH HHS 5R37AI033142NIAID NIH HHS R01 AI033142NIAID NIH HHS R01 AI033774NIAID NIH HHS R01 AI052733NIAID NIH HHS R37 AI033142NIGMS NIH HHS 5T34GM007821-31NIGMS NIH HHS T34 GM007821
6 · The paper itself

Abstract

Human infection with Cryptococcus neoformans, a common fungal pathogen, follows deposition of yeast spores in the lung alveoli. The subsequent host-pathogen interaction can result in eradication, latency, or extrapulmonary dissemination. Successful control of C. neoformans infection is dependent on host macrophages, but macrophages display little ability to kill C. neoformans in vitro. Recently, we reported that ingestion of C. neoformans by mouse macrophages induces early cell cycle progression followed by mitotic arrest, an event that almost certainly reflects host cell damage. The goal of the present work was to understand macrophage pathways affected by C. neoformans toxicity. Infection of macrophages by C. neoformans was associated with alterations in protein translation rate and activation of several stress pathways, such as hypoxia-inducing factor-1-α, receptor-interacting protein 1, and apoptosis-inducing factor. Concomitantly we observed mitochondrial depolarization in infected macrophages, an observation that was replicated in vivo. We also observed differences in the stress pathways activated, depending on macrophage cell type, consistent with the nonspecific nature of C. neoformans virulence known to infect phylogenetically distant hosts. Our results indicate that C. neoformans infection impairs multiple host cellular functions and undermines the health of these critical phagocytic cells, which can potentially interfere with their ability to clear this fungal pathogen.

Indexed as

AnimalsApoptosis Inducing FactorCell LineCryptococcus neoformansGene Expression ProfilingGene Expression RegulationGTPase-Activating ProteinsHost-Pathogen InteractionsHypoxia-Inducible Factor 1, alpha SubunitMacrophagesMacrophages, PeritonealMembrane Potential, MitochondrialMiceMitochondriaPhagocytosisProtein BiosynthesisAIFM1 protein, mouseApoptosis Inducing FactorGTPase-Activating ProteinsHif1a protein, mouseHypoxia-Inducible Factor 1, alpha SubunitRalbp1 protein, mouse

Identifiers

PMID25646306
PMCPMC4340727
OpenAlexW1572614984

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.